Overview

Bioequivalence Study of SPARC147609 in Patients With Ovarian Cancer

Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
Bioequivalence study of SPARC147609
Phase:
Phase 1
Details
Lead Sponsor:
Sun Pharma Advanced Research Company Limited